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Abstract

CHARATERIZATION OF PUTATIVE PORPHYROMONAS GINGIVALIS RNABINDING PROTEINS
Holly Dwyer
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University
Virginia Commonwealth University, 2014
Major Director: Dr. Janina Lewis, Ph.D. Associate Professor
VCU Philips Institute for Oral Health Research
Oral and Craniofacial Molecular Biology
School of Dentistry, Virginia Commonwealth University
Porphyromonas gingivalis (P. gingivalis) is a gram-negative, anaerobic bacterium
recognized as a major player in progression of periodontal disease. P. gingivalis survives
in the oral cavity while being exposed to dynamic environmental conditions such as pH,
temperature, nutrient availability and host immune responses such as oxygen tension and
nitrosative stress. Survival and pathogenesis of P. gingivalis in the oral cavity require
mechanisms to regulate gene expression in response to the extracellular signals. Little is
known about the regulatory mechanisms of P. gingivalis in the oral cavity, so it is
important to investigate and characterize these regulatory mechanisms.
Adaptation to environmental cues using riboregulation is a significant mechanism

for post-transcriptional regulation in bacteria. Using bioinformatics, we have identified a
putative RNA-binding protein in P. gingivalis: RBP. Bioinformatic studies have led to the
selection of HUβ and HUα nucleoid associated proteins as controls for RNA binding. I
hypothesize that the candidate proteins RBP, HUβ and HUα bind RNA in P. gingivalis.
The first aim is to show that RBP, HUβ and HUα bind RNA. Using electrophoretic
mobility shift assays with IRE RNA and synthesized RNA motifs, I have confirmed that
the proteins do bind RNA. The second aim is to isolate and sequence the P. gingivalis
RNA that bind to RBP, HUβ and HUα. I have isolated the RNAs that bound the proteins
and determined identity of the RNA using high throughput sequencing. Finally, I have
identified an antibody that specifically binds RBP to use for in vivo immunoprecipitation
of RNA-protein complexes from P. gingivalis. In conclusion RBP, HUβ and HUα are
novel RNA binding proteins in P. gingivalis, and further investigation of these proteins is
necessary to understand the mechanisms of gene regulation in P. gingivalis.
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CHAPTER 1: INTRODUCTION

1.1.

BACKGROUND AND SIGNIFICANCE

1.2.

Periodontal Disease
The oral cavity has a unique bacterial flora that is highly diverse (Aas et al., 2005).

The normal flora of the healthy oral cavity consists primarily of gram-positive organisms
in the plaque biofilm (Ezzo et al., 2003). The shift to a more gram-negative biofilm results
in the development of periodontal disease (Ezzo et al., 2003). The disruption in the
commensalism by proteolytic bacteria leads to inflammation of the periodontal epithelium,
pathogen invasion, and the development of periodontal disease (Darveau, Tanner et al.,
1997). The most prevalent organisms associated with periodontal diseases are
Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Campylobacter
rectus, and Treponema denticola (Ezzo et al., 2003).
Periodontitis is a common oral disease that affects at least 35% of U.S. adults
between the age of 30 to 90 (Albandar et al., 1999) and about 300 million people globally
(Wayakanon et al., 2013). The disease ranges in severity from gum inflammation to a
more serious condition resulting in damage to the soft tissue and alveolar bone that
support teeth.
Gingivitis is the initial stage of the disease characterized by inflammation. During
this stage of gum disease, there is no loss of bone or tissue that holds teeth in place.
Gingivitis can usually be reversed with daily brushing and flossing, and regular cleaning

by a dentist or dental hygienists. If left untreated, gingivitis can develop into periodontitis.
Periodontitis is characterized by severe inflammation of the periodontium caused by
bacterial biofilm on the tooth surface called plaque (Kinane et al., 2008). In severe
periodontitis, gums pull away from the teeth and form pockets that become infected
(Savage et al., 2009). The bacteria of the plaque adhere to the tooth and bone and release
endotoxins and degradative enzymes that trigger a host immune response. The endotoxins
and degradative enzymes in conjunction with our bodies’ inflammatory immune response
break down the alveolar bone and connective tissue that surround and support the teeth,
often resulting in tooth loss (Weinmann et al., 2011).
Periodontitis is also associated with systemic conditions—increased risk of
coronary heart diseases (Nibali et al., 2007; Morrison et al, 1999), pre-term delivery of
underweight infants (Offenbacher et al., 1996), stroke (Pussinen et al., 2004; Pussinen et
al., 2007), atherosclerosis and rheumatoid arthritis (Gibson et al., 2006; Miyakawa et al.;
Morrison et al., 1999). The exact mechanism for the association is unknown but it may be
due to increased circulating cytokines and mediators, direct infection and cross-reactivity
or molecular mimicry (Seymour et al., 2007).
1.2.1

Porphyromonas gingivalis
Porphyromonas gingivalis (P. gingivalis) is an anaerobic, gram-negative, non-

motile bacterium of the family Bacteroidaceae. The increase in P. gingivalis abundance in
the oral microbiome plays a critical role in the development of the chronic inflammatory
disease known as periodontitis. P. gingivalis is often referred to as a “keystone pathogen”
in the development of periodontitis (Hajishengallis et al., 2012). The term “keystone” is
used to describe the species’ grand impact on its community and structure of the biofilm
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(Hajishengallis et al., 2012; Power et al., 1996). As shown in Figure 1, P.
gingivalis, Tannerella forsythia, and Treponema denticola make up the ‘red complex’,
which is well established to be associated with periodontal disease (Holt &
Ebersole, 2000; Kumar et al., 2003; Dewhirst et al., 2010). P. gingivalis’ major role in the
initiation and progression of periodontitis may be used as a risk indicator for periodontal
disease (Ezzo et al., 2003).

Figure 1: Pathogens involved in periodontal disease. (Modified from: Haffajee A,
Sokransky S, “Microbial Goals of Periodontal Therapy”. Periodontology 2000.
2006;42180-210)
1.3.

P. gingivalis Virulence factors
P. gingivalis expresses four major virulence factors: fimbriae, capsule, gingipains

and lipopolysaccharides. The main function of fimbriae is to mediate adhesion and
invasion into host epithelial cells. P. gingivalis fimbriae modulate proinflammatory
cytokine production and also induce T cell activation in mice (Isogai et al., 1994).
The capsule of P. gingivalis aids in immune evasion, promoting survival of the
bacterium within host cells and increasing virulence (Singh et al., 2011). Along with
immune evasion, encapsulation also reduces the host immune response in a variety of
ways. Phagocytosis is reduced, survival increases in the presence of host cells, dendritic
cell maturation induced by P. gingivalis is reduced, and virulence of P. gingivalis is
enhanced compared to non-encapsulated P. gingivalis strains (Singh et al., 2011).
3

P. gingivalis gingipains are proteases that function to degrade proteins into
peptides as a source of nutrients. P. gingivalis utilizes hemin, iron-containing
Protoporphyrin IX, as the primary form of iron (Priyadarshini et al., 2013). P. gingivalis
acquires hemin from hemoglobin via the enzymic activity of gingipains (Priyadarshini et
al., 2013). Gingipains also contribute to evasion of phagocytosis by degrading serum
opsonins and host tissues (Genco et al., 1991). There have been three cysteine proteases
purified from P. gingivalis with site-specific hydrolysis. Two of the proteases hydrolyze
peptide bonds after Arginine residues and one hydrolyzes peptide bonds after Lysine
residues. The proteases have recently been referred to as RGP and KGP or “gingipain R”
and “gingipain K” (Pike et al., 1994). Gingipain R aids in intracellular invasion and
evasion of the host immune response by mediating vascular permeability through
bradykinin release, enhancing binding of fimbriae to fibroblasts, and destroying the
proteins of the complement system (Pike et al., 1994). Gingipain K mediates similar
activities and is currently described as the most potent fibrinogenase (Pike et al., 1994).
In general, gram-negative organisms contain an important amphipathic outer
membrane component called the lipopolysaccharides (LPS). The LPS enhances structural
integrity and contributes to the organism’s biological activity (Ezzo et al., 2003). The LPS
of P. gingivalis has unique properties. Most gram-negative bacteria interact with TLR4 as
the main transmembrane receptor for lipopolysaccharides, while TLR2 is the main
receptor to yeasts and gram-positive bacteria. P. gingivalis is an exception in that it can
interact with TLR2 (Hirschfeld et al., 2001; Pulendran et al., 2001). Surface components
of P. gingivalis including the LPS, lipoproteins, and fimbriae interact with TLR2
expressed on the surface of host cells (Takeda & Akira 2004). TLR2 mediates the
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expression of genes responsible for inflammation (Burns et al., 2006). The activation of
TLR2 by P. gingivalis LSP may allow the pathogen to be able to regulate the class of the
immune response in vivo, favoring a humoral response and enhancing its survival (Ezzo et
al., 2003).
1.4.

Gene Regulation in P. gingivalis

1.4.1. Riboregulation and RNA-binding proteins in Eubacteria
Regulation of protein translation by small non-coding regulatory RNA (sRNA) and
RNA binding proteins is rapidly becoming a focus in the studies of pathogenic bacteria
(Phillips et al., 2013). Studies have shown that regulation of protein expression by RNAs
and their associated proteins is much more widespread than previously thought (Beisel et.
al 2010). These regulatory RNAs and RNA binding proteins are known as riboregulators.
RNAs are effective regulatory molecules that can influence protein expression and
function in response to external signals such as temperature, pH, and metabolite levels
(Gripenland et al., 2010).
Riboregulation is an efficient mechanism for rapidly regulating translation in
bacteria in diverse environmental conditions. First of all, evidence shows that generating
riboregulators and target RNAs through transcription requires much less energy than
translating regulatory proteins (Gripenland et al, 2010). Secondly, riboregulators can
control translation much faster than regulatory proteins (Gripenland et al, 2010). For
example, 5’ untranslated regions directly dictate the expression of the downstream mRNA
(Gripenland et al, 2010). Also, RNAs can rapidly terminate signal by degrading when no
longer needed since they are usually much less stable than proteins. Lastly, many
riboregulators can act post-transcriptionally to modify mRNAs (Gripenland et al, 2010).
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The riboregulators can work in a variety of ways. Cis-acting RNAs are expressed
from the opposite DNA strand and act in an antisense manner to control translation of
mRNAs (Gipenland et al., 2010). Trans-acting small non-coding RNAs, sRNAs are
expressed from a different location on the chromosome and act at a distance to regulate
RNA translation in an antisense manner (Waters et al., 2009). Bacterial sRNAs typically
range in length from about 50 to 300 nucleotides (De lay N et al., 2013). Bacterial sRNAs
and RNA-binding proteins bind to target mRNA by imperfect base pairing, dependent on
the sRNA's secondary structure (Phillips et al., 2014). As depicted in Figure 2, Base
pairing can lead to stabilization and translational activation of target mRNA (De lay N et
al., 2013). Typically, activation occurs when the sRNA or RNA-binding protein base pairs
within the 5′-UTR, leading to a conformational change of the 5′-UTR, exposing the
ribosome-binding site to allow entry of the ribosome and translation to occur (Fröhlich et
al., 2009; Gottesman, 2011). Alternatively, the action of sRNAs and RNA-binding
protein may lead to translational repression and degradation of the target mRNA (De lay
N et al., 2013). In most cases that have been characterized, sRNAs or RNA-binding
proteins base pair on or near the ribosome-binding site of a target mRNA, leading to
inhibition of translational initiation and, usually, the subsequent destabilization of the
target mRNA (De lay N et al., 2013).
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Figure 2: RNA-binding protein interaction with mRNA. When RNA-binding protein
(RBP) binds to messenger RNA (mRNA) and changes its conformation to expose the
ribosome-binding site (RBS), translation is enhanced. (B.) RBP can bind to the mRNA
and hide the RBS, thus inhibiting translation.
1.4.2. Accessory RNA-Binding Proteins
Also, RNA-binding proteins often bind to the sRNA as an accessory protein.
Illustrated in Figure 3, accessory proteins interact with the sRNAs to stabilize the RNA,
facilitate sRNA-mRNA binding, or degrade the RNA—adding another level of regulation.
So far, the accessory proteins have been classified as either chaperones or RNases.
Molecular chaperones are proteins that bind to the RNA and assist in folding or unfolding.
Trans-acting sRNAs often require a chaperone protein for stability and to facilitate
binding with the target mRNA (Beisel et al., 2010; Waters et al., 2009; Soper et al., 2008).

7

Figure 3: RNA-binding protein (RBP) interaction with sRNA to stabilize sRNA and
to enhance binding of sRNA to mRNA to regulate gene expression. (A.) When sRNARBP complex binds to mRNA and changes its conformation to expose the RBS,
translation is enhanced. (B.) When the sRNA-RBP complex binds to the mRNA and hides
the RBS, translation is inhibited.
A well studied and common RNA binding protein known as Hfq has been found in
about half of bacteria and functions as a chaperone for sRNAs. The chaperone protein Hfq
in E. coli facilitates the binding of stable trans-acting sRNA with the target mRNA target
(Gripenland et al, 2010). Hfq has been shown to participate in virulence in many gramnegative bacteria (Gripenland et al, 2010).
RNases are enzymes that govern the maturation and degradation of target mRNAs
and trans-acting sRNAs (Anderson et al, 2009). Endonucleases cleave within the
transcript, and exonucleases cleave at the 5’ or 3’ ends of the transcripts (Gripenland et
al., 2010).
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1.4.3. HU Nucleoid-associated proteins
HU protein is one of the most abundant nucleotide-associated proteins (NAPs) in
the bacterial cell. HU binds to nicked or gapped DNA–RNA hybrids and to small noncoding RNA molecules (Balandina et al., 2002). HU has been shown to compact and
prevent denaturation of DNA under harmful conditions (Drlica & Rouviere-Yaniv,
1987; Oberto et al., 2009; Swinger & Rice, 2004) and to be involved in changing DNA
topology specifically by introducing negative super coiling into relaxed DNA in the
presence of topoisomerase I. HU acts as an accessory protein in most types of
nucleoprotein-mediated processes (Drlica & Rouviere-Yaniv, 1987; Grove, 2011), such
as acting as a cofactor to either stimulate or repress transcription (Aki et al.,
1996; Morales et al., 2002) or aiding in translation (Balandina et al., 2001).
It was found that HU binds to RNA just as it does to supercoiled DNA, previously
believed to be the major target for the nucleoid-associated HU (Rouviere-Yaniv et al.,
Balandina et al., 2002). Contrary to previous beliefs, HU has recently been recognized to
bind with high affinity to mRNA from rpoS. This gene encodes the stress sigma factor of
RNA polymerase, stimulating its translation (Balandina et al., 2001).
1.5.

Mechanisms of regulation in P. gingivalis
The dynamic environment and host immune responses cause stress to the

organisms residing in the oral cavity. In order to survive and thrive in a hostile
environment, P. gingivalis has to monitor its surroundings and adjust its gene expression.
P. gingivalis scavenges for essential nutrients in the oral cavity; iron in particular is
crucial for establishment and progression of infections (Wooldridge et al., 1993). Studies
assessing gene expression profiles of P. gingivalis strain W83 support the notion that there
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is a regulatory switch that initiates periodontal pathogenesis during mid-log phase under
hemin limitation (Kiyama-Kishikawa et al., 2005). The regulatory systems used by P.
gingivalis to rapidly respond to these and other environmental cues remain unclear
(Phillips et al., 2013).
Transcriptional regulatory mechanisms reported in P. gingivalis include the twocomponent system (Hasegawa et al., 2003; Nishikawa & Duncan, 2010), extracytoplasmic
function (ECF) sigma factor (Dou et al., 2010; Yanamandra et al., 2012), and transposasemediated regulation (Lewis et al., 2009).
(i) Two-component system
In P. gingivalis the first two-component system identified was FimS–FimR
(Hayashi et al., 2000). In this regulatory mechanism (Fig. 4), an unknown environmental
signal is received by the FimS sensor kinase and transmitted to the associated FimR
response regulator in the cytoplasm. The activated FimR up-regulates the transcription of
the fimX–pgmA operon, followed by the expression of fimA, encoding a major subunit
fimbrilin (FimA), in a FimX-dependent manner. Finally, the expressed FimA acts as a
positive regulator for the transcription of downstream genes encoding minor structural
components (Yoshimura et al., 2009).
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Figure 4: Schematic representation of P. gingivalis two-component system regulatory
mechanism FimS–FimR. (Figure adapted from Yoshimura et al., 2009)
(ii) Extracytoplasmic function (ECF) sigma factor
P. gingivalis responds to environmental signals by regulating at the level of
transcription initiation involving alternative sigma factors. Sigma factors recruit RNA
polymerase and facilitate specific promoter recognition and transcription initiation (Paget
& Helmann, 2003). The P. gingivalis W83 genome encodes eight sigma factors, six of
which belong to the ECF sigma factor subfamily (PG0162, PG0214, PG0985, PG1318,
PG1660, and PG1827) (Nelson et al., 2003). Several of the ECF sigma factors may play a
role in virulence regulation and adaptation to oxidative stress. ECF sigma factors encoded
by the PG0162 and PG1660 genes are likely involved in the post-transcriptional
regulation of the gingipains (Dou et al., 2010).

11

(iii) Transposase-mediated regulation
Bacterial insertion sequences (IS) can mediate genetic effects in their host cells.
They are able to inactivate single genes by insertion and creation of mutations via
transposition. Insertion sequences can inactivate multiple genes due to polarity effects
(Galas and Chandler, 1989). Transposition can also cause transcriptional activation of
dormant genes by outward-firing IS promoters or by creation of new promoters resulting
from the insertion event (Podglajen et al., 1995). Insertion sequences may facilitate
genomic rearrangements such as deletions and inversions by acting as sites for
homologous recombination or as the result of their mobility (Lewis and Macrina, 1998).
Transposition might function as a means to control virulence gene expression
in P. gingivalis, particularly in the case of protease gene inactivation. Lewis and Macrina
investigated the sequence IS195 interrupting the prtP gene and concluded that it was a
novel IS-like element (Lewis and Macrina, 1998).
(iv) Riboregulation in P. gingivalis
There is significant work suggesting that sRNA-mediated post-transcriptional
regulation is a conserved mechanism among pathogenic bacteria to modulate bacterial
virulence and survival. In one particular study, P. gingivalis sRNA expression profiles
were generated in response to growth phase, hemin availability after hemin starvation, or
both (Phillips et al., 2014). By employing RNA-seq analysis to identify and characterize
the expression profile of small RNA transcripts expressed in P. gingivalis, a list of
possible regulatory transcripts was generated. The study identified highly expressed
transcripts of sRNAs, some of which are hypothesized to be involved in genetic exchange
using transposition. Overall, this approach provided a comprehensive way to examine
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transcriptional activity to investigate RNA transcripts involved in responding to
environmental signals (Phillips et al., 2014).
Most sRNAs currently characterized in bacteria are stabilized by Hfq. Hfq is a
chaperone conserved across many bacterial species (Beisel & Storz, 2010; Richards &
Vanderpool, 2011; Storz et al., 2011; Vanderpool et al., 2011; Bossi et al., 2012; Richter
& Backofen, 2012; Sobrero & Valverde, 2012). However, P. gingivalis is among the 50%
of bacteria known as an Hfq-negative bacterium, and its sRNA regulatory system is
currently uncharacterized. As of yet, there is no RNA-binding protein identified in P.
gingivalis. Among the bacterial species implicated as aetiological agents of periodontal
disease, P. gingivalis is most intensely investigated, and therefore has been chosen as a
model for pathogen riboregulation in the oral cavity (Lewis, 2010).
1.6.
(i)

Candidates for P. gingivalis RNA Binding Proteins (RBPs)
RBP (PG0565, PG0627)
RBP is a putative RNA-binding protein in P. gingivalis based on bioinformatics.

The BROP program shows numerous significant hits in BLAST to other RNA-binding
proteins (Table 1). Also, unpublished data from the Lewis lab has shown that RBP
knockouts cannot survive the innate immune responses of eukaryotic cells.
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Table 1: Candidate Protein RBP information (Oralge database:
http://www.oralgen.org/cgibin/gene_id_search.cgi?dbname=pgin&gene_id=PG0565)
LANL Gene ID
GenBank Locus Tag
DNA Molecule
Name
GenBank ID
Definition
Cellular location
Gene Start
Gene Stop
Gene Length
Molecular Weight
pI
Net Charge
Functional Class
Blast Summary

PG0565
PG0627
1
34540433
RNA binding protein
Cytoplasm
681526
681236
291
11,484
5.40
-1.76
Transcription
Numerous significant hits in gapped BLAST to RNA binding
protein.
Residues 1-76 are 53% similar to gbAAC65342.1 RNA-binding
protein, putative of Treponema pallidum.
Residues 3-76 are 54% similar to gbAAA85379.1 RNA binding
protein of Synechocystis sp.
Residues 1-76 are 50% similar to gbAAC47624.1 putative RNA
binding protein of Brugia malayi.

RBP Amino Acid Sequence:
MSMNIYVGNLNYRVREEDLTGLLQQYGAVTSARVITDRETGRSRGFGFVE
MEDENDARRAIEELFDQEFQGRKLIVKEALERPERAPRRTFRHEDRY

Figure 5: Locus of RBP (PG0565) in P. gingivalis genome. (Oralgen.org)
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1.6.1. HU Proteins in P. gingivalis
The genome of P. gingivalis is predicted to encode both the HUα (PG1258) and
the HUβ (PG0121) subunit (Table 2 and 3). There are twelve genes in the P. gingivalis
W83 genome that are annotated by BROP databse as histone-like DNA-binding proteins
that are related to HU, but some are longer and have distinct domain architecture. These
proteins have a separate superfamily known as TIGR1201.
(ii)

HUβ (PG0106, PG0121)

The gene PG0121 encodes a functional homologue of E. coli HU and shares 76.7%
sequence similarity to E. coli HUβ (Pearson & Lipman, 1988; Priyadarshini et al., 2013).
Also, HUβ from the P. gingivalis genome has the ability to complement some HU
functions in E. coli HU double mutants (Priyadarshini et al., 2013).
HUβ has global regulatory functions in P. gingivalis and is differentially expressed
at the level of transcription during different phases of growth (Priyadarshini et al.,
2013). HUβ affects surface polysaccharides production for capsule synthesis and also
expression of genes involved in basic functions such as cell division, iron uptake, cell wall
synthesis, translation and DNA binding (Priyadarshini et al., 2013). The expression of the
K-antigen capsule operon may be regulated by HUβ’s interaction with RNA structures,
but the ability of HUβ to bind to RNA has not been tested (Tjokro et al., 2014). In E. coli,
HU has been shown to bind upstream of rpoS mRNA, which encodes the RNA
polymerase stress sigma factor. This binding results in increased RpoS protein expression
(Balandina et al., 2001). It is hypothesized that the expression of the K-antigen capsule is
regulated by a similar mechanism (Tjokro et al., 2014).
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Table 2: Candidate RNA-binding protein HUβ information (Oralgen database:
http://www.oralgen.org/cgi-bin/gene_id_search.cgi?dbname=pgin&gene_id=PG0106)
LANL Gene ID
GenBank Locus Tag
DNA Molecule Name
GenBank ID
Definition
Cellular location
Gene Start
Gene Stop
Gene Length
Molecular Weight
pI
Net Charge
Functional Class
Blast Summary

PG0106
PG0121
1
34539986
DNA-binding protein (HU-related)
Cytoplasm, Periplasm
144608
144871
264
9461
11.00
7.98
DNA metabolism; chromosome-associated proteins
Numerous significant hits to DNA-binding protein in gapped
BLAST.
Residues 1-86 are 54% similar to dbj|BAA07273.1| DNA
binding protein HU of Bacillus stearothermophilus.
Residues 1-86 are 54% similar to dbj|BAB05028.1| non-specific
DNA-binding protein II (HB) (HU) of Bacillus halodurans.
Residues 1-86 are 51% similar to pir||DNZRH3 DNA-binding
protein of Rhizobium leguminosarum.

HUβ Amino Acid Sequence:
MNKTDFIAAVAEKANLTKADAQRAVNAFAEVVTEQMNAGEKIALIGFGTF
SVSERAARKGINPKTKKSISIPARKVVRFKPGSTLELK

Figure 6: Locus of HUβ (PG0106) in P. gingivalis genome. (Oralgen.org)
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(iii)

HUα (hup, PG1258)

Previous studies indicate that HUα is essential for growth in P. gingivalis strain
W83 (Alberti-Segui et al., 2010; Klein et al., 2012). The P. gingivalis gene PG1258 has
been shown to encode a homolog of E. coli HUα (Tjokro et al., 2014). The P. gingivalis
HUα shares 71.1% amino acid similarity to E. coli HUα (Peason & Lipman, 1988). In
other organisms HUα will compensate for the lack of HUβ, but in a study using P.
gingivalis with deletion of PG0121, microarray and qRT-PCR data indicated that
transcription of PG1258 is not significantly altered in the PG0121 HU mutant
(Priyadarshini et al., 2013). These results indicate that HUα may not play a compensatory
role in P. gingivalis (Priyadarshini et al., 2013). P. gingivalis HUα may play an
important role in ensuring proper function of HUβ, but further studies are required in order
to confirm the role of HUα in a heterodimer and to more thoroughly understand the
function of HUα (Tjokro et al., 2014).

17

Table 3: Candidate RNA-binding protein HUα information (Oralgen database:
http://www.oralgen.org/cgi-bin/gene_id_search.cgi?dbname=pgin&gene_id=PG1111)
LANL Gene ID
GenBank Locus Tag
DNA Molecule Name
GenBank ID
Gene name
Definition
Cellular location
Gene Start
Gene Stop
Gene Length
Molecular Weight
pI
Net Charge
Functional Class
Blast Summary

PG1111
PG1258
1
34540963
hup
histone-like DNA binding protein, IHFA, IHFB, or DBH
Cytoplasm, Periplasm
1334955
1334680
274
10282
10.40
4.99
DNA metabolism; DNA replication, recombination and repair
Numerous significant and weak hits to DNA-binding protein in
gapped BLAST.
Residues 1-90 are 38% similar to dbj|BAA07273.1| DNA
binding protein HU of Bacillus stearothermophilus.
Residues 1-83 are 42% similar to pir||JC1208 DNA-binding
protein HU of Bacillus subtilis.
Residues 1-83 are 40% similar to dbj|BAB05028.1| non-specific
DNA-binding protein II (HB) (HU) of Bacillus halodurans.

HUα Amino Acid Sequence:
MTKADVVNAIAKSTGIDKETTLKVVESFMDTIKDSLSEGDNVYLRGFGSF
IVKERAEKTARNISKQTTIIIPKRNIPAFKPSKIFMSQMKQD

Figure 7: Locus of HUα (hup, PG1258) in P. gingivalis genome. (Oralgen.org)
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CHAPTER 2: HYPOTHESIS AND AIMS

2.1.

Hypothesis
We hypothesize P. gingivalis candidate proteins RBP (PG0565), HUβ (PG0121)

and HUα (PG1258) bind to RNA in P. gingivalis.
2.2.

Research Objective and Aims
The main objective of this research work is to investigate the interaction of the

candidate proteins: RBP (PG0565), HUβ (PG0121) and HUα (PG1258) with RNA in P.
gingivalis. Flowchart illustrating our work plan is shown in Fig. 8.
Aim 1: To test the binding of candidate proteins RBP (PG0565), HUβ (PG0121) and HUα
(PG1258) with RNA using:
I.

Preparation of recombinant proteins

II.

Electophoretic Mobility Shift Assays (EMSA) using labeled and
competitor RNA

III.

EMSA using synthesized RNA strands with specific motifs

Aim 2: To isolate the P. gingivalis W83 RNA bound to RBP (PG0565), HUβ (PG0121)
and HUα (PG1258), and to sequence the RNA using:
I.

Pulldown assay to isolate the protein-RNA complexes
a. His-tag Pulldown
b. HaloTag Pulldown

II.

RNA sequencing and library generation of P. gingivalis W83 RNA

19

Figure 8: Flowchart of the project aims and methods
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CHPATER 3: MATERIALS AND METHODS

3.1.

Bacterial Strains and Plasmids

The bacterial strains and plasmids used in this study are listed in Table 4.
Table 4: Bacterial strains and plasmids used in this study
Strain
Top10

E. coli

α-Select
Silver
BL21

Plasmid
pCR2.1TOPO
pET-30a

Description
Kanamycin resistance
Ampicillin resistance
His-Tag
Kan coding sequence
His-Tag
Kan coding sequence
HaloTag T7 SP6 Flexi
Vector
Kanamycin resistance

pET-30a
pFC20K

P. gingivalis

3.2.

W83

Parental
Strain

Reference
Invitrogen
Bioline
Novagen
Promega
Lewis et al.,
1998

Media Growth Conditions

I. Escherichia coli
Escherichia coli (E. coli) was grown aerobically at 37 °C in Luria-Bertani (LB)
broth (Invitrogen; cat. no. 12780029) or on LB agar. Kanamycin (50 µg/mL) was added to
select for recombinant strains.
II. Porphyromonas gingivalis
Porphyromonas gingivalis (P. gingivalis) strain W83 was grown anaerobically at
an atmosphere of 10% H2, 10% CO2 and 80% N2 at 37°C. Bacteria liquid cultures were
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prepared in Brain-Heart infusion broth (BHI; Difco Laboratories, Detroit, Mi) with hemin
(5 µg/mL; Sigma, St. Louis, MO), yeast extract (5 mg/mL) cysteine (1mg/mL; Sigma, St.
Louis, MO) and vitamin K3 (1 µg/mL; Sigma, St. Louis, MO).
3.3.

Creating recombinant RBP, HUβ, and HUα with His-Tag

3.3.1

PCR amplification of genes PG0565, PG0121, and PG1258
PCR was performed using PCR SuperMix (Invitrogen) to amplify gene PG0565,

PG0121, and PG1258. 35 cycles were performed of denaturing at 94°C for 30 sec,
annealing at 52 °C for 30 sec, and extending at 72°C for 3 min. Gel electrophoresis was
used to confirm the size of the amplified fragment. The PCR product was then extracted
from gel using Qiagen Mini Elute PCR Purification Kit (Qiagen).
RBP primers:
1F: CGA GGC CAT GGC TAT GAG TAT GAA CAT CTA CGT AG
1R: GCG TGC TCG AGT CAA TAG CGA TCT TCG TGT CGG
HUβprimers:
2F: CGA GGC CAT GGC TAT GAA CAA GAC AGA TTT TAT TGC AG
2R: GGT GCT CGA GTT ACT TAA GTT CCA AAG TAG AGC
HUα primers:
3F: CGA GGC CAT GGC TAT GAC GAA AGC TGA CGT AGT GAA CG
3R: GGT GCT CGA GTT AGT CTT GTT TCA TCT GAC TC
3.3.2

Cloning and Transformation
Purified PCR product of amplified gene PG0565, PG0121, and PG1258 were

cloned using TA cloning kit into vector pCR2.1-TOPO (Invitrogen) illustrated in Figure 9.
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Figure 9: Diagram of vector pCR2.1-TOPO (adapted from Invitrogen).
The vector was transformed into Top10 cells (Invitrogen) using the heat shock
method. IPTG and x-gal were used when plating to screen for recombinant colonies.
Overnight cultures were prepared from white colonies and plasmids were purified using
the Q1prep Spin Miniprep Kit (Qiagen; cat. no. 27104). Colonies were screened using
restriction enzyme EcoRI digest. The inserts and vector pET-30a were digested using
restriction enzymes NcoI and XhoI, and electrophoresed on 1% agarose gel. The gene
inserts PG0565, PG0121, and PG1258 and the pET-30a vector were isolated using a gel
extraction kit, (Qiagen, Mini Elute Gel Extraction Kit). PG0565, PG0121, and PG1258
gene inserts were ligated into pET-30a (Novagen; Fig. 10) using T4 DNA Ligase (New
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England Biolabs) and transformed into α-Select Silver E. coli (Bioline). The
transformations were screened on LB plates with kanamycin and colonies were cultured
overnight in 20mL of LB media.

Figure 10: Diagram of pET-30a vector (adapted from Novagen). Restriction enzymes
used for insertion: XhoI and NcoI. The “kan” designates a gene encoding kanaycin
resistance that in turn allows for colony selection using kanamycin.
Overnight cultures were prepared and plasmids were purified using the Q1prep
Spin Miniprep Kit (Qiagen; cat. no. 27104). Insert was verified using restriction enzymes
NcoI and XhoI. The pET-30a plasmid with insert was purified using the QIAprep Spin
Miniprep Kit (Qiagen; cat. no. 27104). The plasmids were then transformed into BL21
competent E. coli cells for protein expression using the heat shock method.
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3.3.3. Creating recombinant RBP with C-Terminal His-Tag
3.3.4. PCR Amplification of PG0565
PCR was performed to amplify gene PG0565, and then purified using Qiagen Mini
Elute PCR Purification Kit.
Primers:
F1 new:
CTT CCA GGG ATC CCC AGA ATT CGA TCT TCT TCT GAA AGC CTG
CGA GGC CAT GGC TAT GAG TAT GAA CAT CTA CGT AG
R1 new:
GCG CAC TCG AGT TAC TCC AGC CTC GAC AAT CGG
Purified PCR product of gene PG0565 cloned using TA cloning kit into vector
pCR2.1-TOPO (Invitrogen; Fig. 9). The vector was transformed into Top10 cells
(Invitrogen) and selected for with IPTG and x-gal used to screen for recombinant colonies.
Overnight cultures were prepared from white colonies and plasmids were purified using
the Q1prep Spin Miniprep Kit. Colonies were screened using restriction enzyme EcoRI
digest. The insert and pET-30a (Fig. 10) were digested using restriction enzymes NdeI and
XhoI, and electrophoresed on 1% agarose gel. The insert containing gene PG0565 and
vector pET-30a were isolated using a gel extraction kit, (Qiagen, Mini Elute Gel
Extraction Kit). The insert was then cloned into pET-30a vector (Novagen) using T4 DNA
Ligase and transformed into α-select Silver competent cells (Bioline) using heat shock
technique.
Overnight cultures were prepared and plasmids were purified using the Q1prep
Spin Miniprep Kit. Insert was verified using restriction enzymes NdeI and XhoI. The pET-
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30a plasmid with insert was purified using the QIAprep Spin Miniprep Kit (Qiagen; cat.
no. 27104). The plasmids were then transformed into BL21 competent E. coli cells) using
heat shock technique.

3.3.5. Creating recombinant RBP, HUβ, and HUα with Halo-Tag
Other members in the lab had prepared pFC20K HaloTag plasmids (Fig. 11)
pFC20K-RBP, pFC20K-HUβ, and pFC20K-HUα.

Figure 11: pFC20K HaloTag Diagram (adapted from Promega). Gene insertion replaces
lethal gene named barnase to create recombinant plasmids: pFC20K-RBP, pFC20K-HUβ,
and pFC20K-HUα.
Barnase is a lethal gene that is replaced when the gene of interest is inserted into the
plasmid. The Halotag is used to bind covalently to Halotag resin to purify recombinant
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protein. The TEV site is the cleavage site of the protease to release recombinant protein
from the resin during purification. The Kan’ designates a gene encoding kanaycin
resistance that in turn allows for colony selection using kanamycin.
The plasmids were then transformed into BL21 cells using the heat shock technique,
plated on Kan LB agar plates, and incubated overnight at 37°C.
3.4.

Purification of recombinant proteins by affinity chromatography

3.4.1

His-Tag Purification of RBP, HUβ, and HUα
1L BL21 cell cultures in LB media were induced with IPTG at OD of 0.6 and

incubated overnight at 37°C. Cultures were centrifuged into pellets and re-suspended in
binding buffer. Binding buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 10 mM
imidazole (IMD) at pH 8.0. Cells were lysed using lysozyme and sonication techniques,
centrifuged, and supernatant was saved. Ni-NTA agarose (Qiagen; cat. No. 30210) was
added to lysate to conduct His-tagged purification by gravity-flow chromatography. The
Ni column was washed with 100mL wash buffer. Wash buffer contained 50 mM
Na2HPO4, 300 mM NaCl, and 20 mM IMD. His-tagged proteins were eluted using an
elution buffer that contained 50 mM Na2HPO4, 300 mM NaCl, and 250 mM IMD.
Elutions were collected and run on NuPAGE® 12% Bis-Tris precast gel (Life
technologies).
3.4.2. Size Exclusion chromatography of RBP
RBP was further purified using size exclusion high performance liquid
chromatography (SE-HPLC). The flowthrough from the Ni-agarose column purification
was applied to the SE-HPLC and aliquots were collected and analyzed using SDS-PAGE
analysis.

27

3.4.3. Purification of C-terminal His-Tagged RBP
1L BL21 cell culture was induced with IPTG at OD of 0.6 and incubated overnight
at 37°C. Cultures were centrifuged into a pellet and re-suspended in binding buffer.
Binding buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 10 mM IMD at pH 8.0.
Cells were lysed using lysozyme and sonication techniques, centrifuged, and supernatant
was saved. Ni-NTA agarose (Qiagen; cat. No. 30210) was added to lysate to conduct Histagged purification by gravity-flow chromatography. Column was washed with 100mL
wash buffer. Wash buffer contained 50 mM Na2HPO4, 300 mM NaCl, and 20 mM IMD.
His-tagged protein was eluted using an elution buffer that contained 50 mM Na2HPO4,
300 mM NaCl, and 250 mM IMD. Elutions were collected and run on NuPAGE® 12%
Bis-Tris precast gel (Life technologies).
3.4.4. His-Tag Repurification on Dynabeads
The RBP, HUα, and HUβ from his-tag column purifications were dialyzed in
binding buffer overnight at 4°C. Binding buffer contained 50 mM Na2HPO4, 300 mM
NaCl, and 10 mM Imidazole at pH 8.0. The proteins were then applied to the Dynabeads
and let incubate for 1hr at 4°C. The beads were placed on a magnet separation device, and
supernatant was decanted. The beads were then washed with nuclease free binding buffer,
placed on a magnet and supernatant decanted. The wash process was repeated 4 times. The
proteins were eluted using nuclease free elution buffer containing 50 mM Na2HPO4, 300
mM NaCl, and 300mM IMD at pH 8.0. The proteins were then dialyzed in nuclease free
binding buffer overnight at 4°C.
3.4.5. HaloTag Protein Isolation
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BL21 colonies were selected and cultured in Kan LB broth. 80mL BL21 cell
cultures were induced with IPTG at OD of 0.6 and incubated overnight at 37°C. After the
cell cultures were induced, they were centrifuged, and media was disposed. The cell pellet
was washed with Purification Buffer, which contains 8.75 g/L NaCl, 11.9 g/L Hepes, and
1mM TCEP. The pellet was resuspended in 18 mL of purification buffer. 2 mL CelLytic B
reagent (Sigma-Aldrich) was added to the suspension and incubated for 20 minutes. The
cell lysates were spun down at 12,000 RPM for 15 minutes.
To equilibrate the Halo link resin, the resin was mixed well and 1mL per 250mL
original culture was added to a clean falcon tube. 20 mL of nuclease free purification
buffer was added to the resin and spun at 2,000 RPM for 2 minutes. The buffer was
removed by pipetting and repeated 2 more times.
The cell lysate was applied to the resin and incubated at for 45 minutes at room
temperature on a rocker. The resin-tagged protein was then washed with 20 mL RNase
free pulldown buffer that contained 3.25 mM Sodium phosphate and 70 mM NaCl, pH
7.4, and centrifuged at 2,000 RPM for 2 minutes. The wash was repeated 2 more times. 3
mL was left in the tube after the final wash. 100 µL TEV mix was added to each sample
and incubated overnight at 4°C to release the protein from the covalent bond.
3.5.

Electrophoretic Mobility Shift Assay

3.5.1

Binding Reactions
The Light Shift® Chemiluminescent RNA EMSA Kit was used to perform gel

shift assays for the three candidate proteins. The control RNA used in this kit is an Iron
response element (IRE) RNA. IRE is RNA with hairpin structure found in untranslated
regions (UTRs) of various mRNAs that encode proteins involved in control of iron
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metabolism (Piccinelli & Samuelsson, 2007). The positive control included in this kit is
cytosolic liver extract. The protein in cytosolic liver extract that binds RNA is the
cytosolic aconitase. Cytosolic aconitase is an IRE-binding protein which may regulate
translation of mitochondrial aconitase mRNA (Zheng et al., 1992). The binding reactions
were assembled according to protocol in the order listed in Tables 5, 6 and 7 on ice.
Reactions were incubated on ice for 30 minutes.
Biotinylated IRE Control RNA (125nM):
5’ –UCCUGCUUCAACAGUGCUUGGACGGAAC—3’ –Biotin
Unlabeled IRE Control RNA (10 µM):
5’ –UCCUGCUUCAACAGUGCUUGGACGGAAC—3’
Synthesized Biotin Labeled RNA Probes:
Long :
5'- rGrGrG rGrArU rUrGrC rArCrG rUrUrU rUrUrU rUrUrU rUrGrC rArUrG
rUrUrU rUrUrU rUrUrG rUrGrU rGrUrU rArUrU rGrCrA rCrGrG rGrGrG rGrGrG
rG/3Bio/ -3'
Short:
5'- rUrUrG rGrUrU rUrUrA rUrUrG rCrUrU rUrGrC rArC/3Bio/ -3’
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Table 5: Binding reaction 1 using IRE control RNA from The Light Shift®
Chemiluminescent RNA EMSA Kit
Nuclease
Free Water
(µL)
10X
REMSA
Binding
Buffer (µL)
50%
Glycerol
(µL)
tRNA
(10mg/mL)
(µL)
Unlabeled
IRE RNA
(µL)
Cytosolic
Liver
Extract
(µL)
Biotin—
IRE
Control
RNA (µL)

Nuclease
Free Water
(µL)
10X
REMSA
Binding
Buffer (µL)
50%
Glycerol
(µL)
tRNA
(10mg/mL)
(µL)
Unlabeled
IRE RNA
(µL)
HUα (µL)
Biotin—
IRE
Control
RNA (µL)

Final
Amount
---

Control
#1
14.8

Control
#2
12.8

Control
#3
10.8

#4

#5

#6

#7

4.8

2.8

4.8

2.8

1X

2

2

2

2

2

2

2

5%

2

2

2

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

0.2

0.2

0.2

1 µM

---

---

2

---

2

---

2

4 µg

---

2

2

10

10

10

10

6.25 nM

1

1

1

1

1

1

1

Final
Amount
---

#8

#9

#10

#11

4.8

2.8

11.8

9.8

1X

2

2

2

2

5%

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

1 µM

---

2

---

2

10

10

3

3

1

1

1

1

6.25 nM

Lysozyme
(µL)
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RBP
(µL)

HUβ
(µL)

Table 6: Binding reaction 2; dose dependent binding reactions of RBP using IRE
control RNA from The Light Shift®
Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)
tRNA (10mg/mL)
(µL)
Unlabeled IRE
RNA (µL)
Cytosolic Liver
Extract (µL)
Biotin—IRE
Control RNA (µL)
Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)
tRNA (10mg/mL)
(µL)
Unlabeled IRE
RNA (µL)
RBP (µL)

Final
Amount
---

#1

#2

#3

14.8

12.3

9.8

1X

2

2

2

5%

2

2

2

2 µg

0.2

0.2

0.2

1 µM

---

---

2

4 µg

---

2

2

6.25 nM

1

1

1

---

#4
14.3

#5
12.8

#6
10.3

#7
5.3

#8
0.3

1X

2

2

2

2

2

5%

2

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

0.2

1 µM

---

---

---

---

---

1

2.5

5

10

15

Biotin—IRE
Control RNA (µL)

3.12 nM

0.5

0.5

0.5

0.5

0.5

Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)

---

#9
12.3

#10
10.8

#11
8.3

#12
3.3

#13
0

1X

2

2

2

2

2

5%

2

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

0.2

1 µM

2

2

2

2

2

1

2.5

5

10

15

0.5

0.5

0.5

0.5

0.5

tRNA (10mg/mL)
(µL)
Unlabeled IRE
RNA (µL)
RBP (µL)
Biotin—IRE
Control RNA (µL)

3.12 nM
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Table 7: Binding Reaction 3 using RBP and synthesized biotinylated RNA probes

Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)
tRNA (10mg/mL)
(µL)
RBP (µL)

Final
Amount
---

#1

#2

#3

#4

#5

14.8

12.3

9.8

4.8

0

1X

2

2

2

2

2

5%

2

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

0.2

---

2.5

5

10

15

1

1

1

1

1

#6

#7

#8

#9

#10

---

14.8

12.3

9.8

4.8

0

1X

2

2

2

2

2

5%

2

2

2

2

2

2 µg

0.2

0.2

0.2

0.2

0.2

---

2.5

5

10

15

1

1

1

1

1

#11
11.8

#12
11.8

1X

2

2

5%

2

2

2 µg

0.2

0.2

3

3

1 µL
Long

1 µL
Short

Biotin Labeled
LongProbe (µL)
Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)
tRNA (10mg/mL)
(µL)
RBP (µL)
Biotin Labeled
Short Probe (µL)
Nuclease Free
Water (µL)
10X REMSA
Binding Buffer
(µL)
50% Glycerol (µL)
tRNA (10mg/mL)
(µL)
Lysozyme (µL)
Biotin Labeled
Probe (µL)

3.5.2. Electrophoresis of Binding Reactions
5 µL of 5X loading buffer was then added to each of the reactions. The wells of the
Novex® TBE 10% gel were flushed with cold nuclease free 1X TBE buffer. 20 µL of
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each sample was loaded onto Novex® TBE 10% gel and run at 100V at 4°C until the dye
has run two thirds of the way down the gel.
3.5.3. Electrophoretic Transfer of Binding Reactions to Nylon Membrane
To prepare for transfer of the binding reaction to the nylon membrane, the
membrane and transfer sponges were soaked in 0.5X nuclease free TBE for at least 10
minutes. The gel was removed from the cast, placed on the membrane, and sandwiched
between sponges. The electrophoretic transfer unit was assembled and filled with cooled
(~10 °C) 0.5X TBE and set on ice. The transfer was run at 300 mA for 50 minutes.
3.5.4. Crosslink Transferred RNA to membrane
When the transfer was complete, the membrane was placed in a clean container
and crosslinked using the auto crosslink function for 45 seconds.
3.5.5. Detect Biotin-labeled RNA by Chemiluminescence
20mL of blocking buffer was incubated on the membrane for 15 minutes and
decanted. Conjugate/blocking buffer solution was added (1:300 dilution), incubated for 15
minutes, and decanted. 20mL of 1X wash solution was added and decanted. The
membrane was then washed 4 more times, each time incubating for 5 minutes. The
membrane was transferred to a new container, and 30mL of substrate equilibration buffer
was added and incubated for 5 minutes. Working solution was prepared by adding 6mL
Luminol/Enhancer Solution to 6mL Stable Peroxide Solution. The membrane was
removed from the Substrate Equilibration Buffer, and placed on clean plastic wrap. The
working solution was poured on top on membrane to cover the entire surface. The
membrane was incubated for 5 minutes and was removed, blotted, and wrapped in clean,
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dry plastic wrap. The membrane was then exposed to a film cassette for 3 minutes in a
dark room and placed in the Kodak develop machine.
3.6.

Protein-RNA Pulldown

3.6.1. RNA Isolation
Using the Qiagen RNeasy® kit, RNA was isolated from P. gingivalis W83, and
then treated with DNA-free™ kit (Ambion). RNA was electrophoresed on an agarose gel
to test for degradation.
3.6.2. Protein-RNA Pulldown using His-Tag on Dynabeads
10 µg of P. gingivalis W83 RNA that was isolated and treated with DNase was
then added to 25 µg purified RBP, HUα, and HUβ. The RNA-protein mixture was
incubated for 1hr at 4°C on a rotator. The mixture was then applied to 50 µL of cobalt
Dynabeads. The pulldown was performed according to Dynabead (Invitrogen) protocol
using nuclease free buffers (Fig 12).
P. gingivalis W83 RNA was added to purified RBP, HUα, and HUβ and let
incubate. The mixture was then applied to 50µL of cobalt Dynabeads and incubated. The
tube was placed on a magnet for 2 min, and the supernatant was discarded. The beads
were washed 4 times with binding buffer by placing the tube on the magnet for 2 min and
discarding supernatant. The beads were thoroughly resuspended between each wash step.
His-elution buffer was added to the beads and incubated on a rotator. The tube was then
placed on the magnet for 2 min and the supernatant was transferred to a new clean tube.
The elution was then treated with protease and used in RNA cleanup for RNA library
generation and sequencing.
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Figure 12: Schematic representation of Protein-RNA Pulldown using Dynabead.
(Modified from Novex by Life Technologies)
3.6.3. Protein-RNA pulldown using Halo-Tag
To equilibrate the Halo link resin, it was mixed up and 1mL per 250mL original
culture was added to a clean falcon tube. 20 mL of nuclease free purification buffer was
added to the resin and spun at 2,000 RPM for 2 minutes. The buffer was removed by
pipetting and repeated 2 more times.
The cell lysate was applied to the resin and incubated at room temperature for 45
minutes on a rocker. 60 µg RNA was added to each of the resin-tagged proteins and
incubated at 4°C for 1 hour. The resin-tagged protein was then washed with 20mL RNase
free pulldown buffer that contained 3.25mM Sodium phosphate and 70mM NaCl, pH 7.4,
and centrifuged at 2,000 RPM for 2 minutes. The wash was repeated 2 more times. 3mL
was left in the tube after the final wash. 100µL TEV mix was added to each sample and
incubated overnight at 4°C (Fig. 13).
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Figure 13: Schematic representation of the Protein-RNA Pulldown using HaloTag
isolation. Halotagged protein covalently binds to resin allowing stringent washes to wash
away residual P. gingivalis RNA. TEV protease cleaves between the protein and Halotag
to release the protein-RNA complex.
3.7.

Protease Treatment
90µL of protein-RNA supernatant from the pulldown was treated with protease

from Streptomyces griseus (Sigma, P8811). 4.5µL of 20mg/mL protease stock solution,
4.5µL 10% SDS, and 1.8 µL of 0.5M EDTA was added to the protein-RNA elution and
incubated at 50°C for 1 hour.
3.7.1

RNA cleanup
The Qiagen RNeasy® kit was used to isolate the RNA by following the protocol

for RNA cleanup. Samples were saved at -20°C.
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3.7.2. RNA Library Generation
SMARTer® Stranded RNA-Seq Kit (Clontech® Laboratories) was used according
to protocol to synthesize cDNA, purify cDNA, amplify RNA-Seq library using PCR, and
purify the RNA-Seq library (Fig 14).

Figure 14: Schematic representation of SMARTer® Stranded RNA-Seq Library
generation. (Clontech Laboratories protocol:
http://www.clontech.com/US/Products/cDNA_Synthesis_and_Library_Construction/Next
_Gen_Sequencing_Kits/Strand-Specific_RNA_Seq_Illumina)
The library generated was then sent to the sequencing center (VCU Sanger Hall) to
be validated using the bioanalyzer. High throughput sequence results were then gathered
and analyzed using statistical analysis. Fold change was used to compare the reads from
RBP with HU proteins.
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CHAPTER 4: RESULTS

4.1.

Creating recombinant DNA
The first aim is to test the interaction of candidate proteins: RBP (PG0565), HUβ

(PG0121) and HUα (PG1258) with RNA. In order to examine the binding of candidate
proteins with RNA, we prepared recombinant proteins. We used PCR SuperMix
(Invitrogen) to amplify the target gene sequences. Gel electrophoresis was used to confirm
the size of the fragment (Fig. 15). As expected, the size of the gene PG0565 is
approximately 300 bp; this is what we expected so we could then move on to cloning
PG0565.

Figure 15: Gel Electrophoresis of the PCR amplification of PG0565. Lane 1: Ladder,
Lane 2: PCR product
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4.1.1. Cloning and transformation
To clone the genes into a plasmid, vector pCR2.1 was used. Genes PG0565,
PG0121, and PG1258 were cloned into pCR2.1-TOPO vector using TA cloning kit. After
ligation of the vector and inserts, the recombinant plasmids were transformed into
Invitrogen One Shot TOP10 cells using heat shock method. The transformations were
plated using IPTG and X-gal to select for plasmid with insertion of the genes. White
colonies were cultured overnight and plasmids were purified using Q1prep Sin Miniprep
Kit (Qiagen). Plasmids were digested with EcoRI in order to confirm the insertion of
desired gene (Fig. 16). The screening for insert using restriction enzyme EcoRI showed
that PG1258 is approximately 300 bp and the vector pCR2.1 is approximately 3.9kb as
expected. We could then move on to insert the gene into pET-30a for His-tag protein
expression.
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Figure 16: Gel Electrophoresis image of EcoRI digestion of pCR2.1-PG1258. Lane 1:
ladder, Lane 2: Recombinant plasmid digested with EcoRI
To produce a His-tagged recombinant protein, the genes PG0565, PG0121, and
PG1258 needed to be cloned into vector pET-30a. The genes were thus digested out of
pCR2.1 using XhoI and NcoI. The plasmid pET-30a was also digested with the same
restriction enzymes for sticky end ligation (Fig17). Plasmid pET-30a digested with NcoI
and XhoI showed pET-30a to be approximately 5.4kb. The results of the pCR2.1-PG0565
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digested with NcoI and XhoI show that pCR2.1 is approximately 3.9kb and gene PG0565
is approximately 300bp. The genes could then be ligated with vector pET-30a.

Figure 17: Gel electrophoresis of NcoI and XhoI digested plasmids. Lane 1: Ladder.
Lane 2: pET-30a digested with NcoI and XhoI. Lane 3: pCR2.1-PG0565 digested with
NcoI and XhoI
To amplify inserts PG0565, PG0121, and PG1258, the gene inserts and pET-30a
were ligated using T4 DNA Ligase and transformed into α-Select Silver E. coli (Bioline).
To insure insert in pET-30a, the transformations were grown on kanamycin LB plates and
colonies were cultured overnight in 20mL of LB media. The recombinant pET-30a
plasmids were purified using the Q1prep Spin Miniprep Kit. In order to verify insertion of
appropriate genes, the plasmids were digested with restriction enzymes NcoI and XhoI and
the digestions were run on agarose gel (Fig 18). As shown in Fig. 18, pET-30a is
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approximately 5.4kb and PG0121 is approximately 300bp. In Fig. 18, the results show the
digestion of pET-30a is approximately 5.4kb and PG1258 is approximately 300bp. The
recombinant plasmids were validated and we could then move on to transform the
recombinant plasmids into BL21 competent E. coli for expression of recombinant
proteins.

Figure 18: Gel Electrophoresis of XhoI and NcoI digestion of pET-30a-PG0121 and
pET-30a-PG1258 to verify colonies with insert PG0121 and PG1258 into pET30-a.
Lane 1: Ladder, Lane 2: Recombinant plasmid pET-30a-PG0121 digested with XhoI and
NcoI, Lane 3: Recombinant plasmid pET-30a-PG1258 digested with XhoI and NcoI.
After validating gene insertions into pET-30a, the plasmids were then transformed
into BL21 E. coli. We used BL21 chemically competent E. coli cells because they are
suitable for transformation and protein expression. The BL21 strains were used to express
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and purify recombinant proteins as described in “Materials and Methods”. The elutions
from the His-tag purification on Ni-resin were run on denaturing protein gels to show
protein expression and purity (Fig 19). His-tag purification of RBP, HUβ, and HUα was
analyzed using 12% Bis-Tris gel showing each protein is approximately 16kD. RBP
elution showed some background, while HUβ and HUα are pure. These samples were
then used to continue to electrophoretic mobility shift assays.

Figure 19: SDS-PAGE analysis of his-tag purified RBP, HUβ and HUα. 12% Bis-Tris
gel was used for the analysis. (A.) Lane 1: Ladder, Lane 2:RBP. (B.) Lane 1: ladder, Lane
2: HUβ, Lane 3: HUα.
4.2.

Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assay (EMSA) technique was used to show the

ability of the proteins to bind RNA in vitro. The purified proteins were dialyzed in RNase
free binding buffer so that they could be used in reactions containing RNA. EMSA was
performed as described in “Materials and Methods”. The first reaction as listed in Table 5
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shows the interaction of RBP, HUβ and HUα with control IRE RNA and the effect of
competitor unlabeled RNA on protein-RNA binding. In Figure 20, the control reaction
shows the IRE RNA probe without protein, with Cytosolic liver extract containing
aconitase binding IRE, and with Cytosolic liver extract and competitor RNA. With no
protein added, there was no shift in the probe. There was a shift in the labeled RNA when
liver extract was added. The amount of labeled RNA shifted was decreased with addition
of unlabeled RNA showing binding specificity between the Cytosolic aconitase and IRE
RNA (Fig. 20). This provided a comparison for future binding reactions.

Figure 20: EMSA Control reactions using Liver Extract, biotinylated IRE RNA and
unlabeled IRE RNA. Lane 1: Contains labeled IRE RNA, Lane 2: Contains cytosolic
liver extract and labeled IRE RNA, Lane 3: Contains cytosolic liver extract, unlabeled IRE
RNA (competitor RNA) and labeled IRE RNA
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The control reactions provided a comparison for reactions with RBP, HUβ, HUα
and Lysozyme. Figure 21 shows the results from binding reactions listed in Table 5. There
was no shift visible in the reactions with RBP. There was a shift in the labeled IRE RNA
probe in the reaction with HUβ with a decrease in shift with the addition of competitor
unlabeled RNA. The reaction with HUα showed a shift in the labeled IRE RNA probe
with a decrease in shift of IRE RNA with the addition of competitor unlabeled IRE RNA
probe meaning that the binding is specific. Lysozyme served as a negative control. There
was a shift seen in the lysozyme binding reactions, but was not decreased with the
addition of competitor RNA meaning that the binding is non-specific.

Figure 21: EMSA reaction using RBP, HUβ, HUα and Lysozyme with labeled IRE
RNA probe. Panel a.) RBP: lane 1 contains RBP and labeled IRE RNA, lane 2 contains
RBP, unlabeled IRE RNA, and labeled IRE RNA. Panel b.) HUβ: lane 1 contains HUβ
and labeled IRE RNA, lane 2 contains HUβ, unlabeled IRE RNA, and labeled IRE RNA.
Panel c.) HUα: lane 1 contains HUα and labeled IRE RNA, lane 2 contains HUα,
unlabeled IRE RNA, and labeled IRE RNA. Panel d.) Lysozyme: lane 1 contains
lysozyme and labeled IRE RNA, lane 2 contains lysozyme, unlabeled IRE RNA, and
labeled IRE RNA.
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4.2.1. EMSA dose dependent reactions
In order to further investigate the RBP interaction with RNA, we used increasing
amounts of RBP in the reaction with IRE RNA (Table 6) to observe the change in shift as
the protein concentration increased. Also, the unlabeled IRE RNA was used as the
competitor IRE RNA to compare for specificity. The results (Fig. 22) show an increase in
probe shift (in the red box) as the protein concentration increases. Also, there is an overall
decrease in shift in the reactions containing competitor RNA.

Figure 22: EMSA dose dependent reaction using RBP with labeled and competitor
IRE RNA probe Lanes 1: No protein + probe, Lane 2: Cytosolic liver extract + probe,
Lane 3: Cytosolic liver extract + probe + unlabeled IRE RNA, Lane 4: 0.28 µg RBP +
probe, Lane 5: 0.7 µg RBP + probe, Lane 6: 1.4 µg RBP + probe, Lane 7: 2.8 µg RBP +
probe, Lane 8: 4.2 µg RBP + probe, Lane 9: 0.28 µg RBP + probe + unlabeled IRE RNA,
Lane 10: 0.7 µg RBP + probe + unlabeled IRE RNA, Lane 11: 1.4 µg RBP + probe +
unlabeled IRE RNA, Lane 12: 2.8 µg RBP + probe + unlabeled IRE RNA, Lane 13: 4.2
µg RBP + probe + unlabeled IRE RNA
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4.2.2. Synthesized RNA Motifs
In order to further investigate the RBP interaction with RNA, we synthesized two
biotinylated RNA probes based on the common RNA motifs that bind to proteins. Because
we had many motifs on this one piece of RNA, the probe is named “long” and a shorter
probe named “short”. The EMSA dose dependent reaction was performed as described in
“Materials and Methods” with increasing amounts of RBP in each reaction beginning with
no protein and increasing up to 4.2 µg. One reaction used the long RNA probe and the
next used the short RNA probe with RBP. The results in Figure 23 show the increasing
amount of RBP added to the reaction caused an increase in shift of the labeled RNA
probe. There is no shift observed in the reaction containing lysozyme and long RNA probe

Figure 23: EMSA dose dependent reaction with increasing concentration of RBP
protein incubated with “long” RNA probe. Black box designates the shift in long probe.
Lysozyme was used as the negative control.
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The results of the dose dependent reaction with short probe are shown in Figure
24. There was no shift in short RNA probes with addition of RBP. The increasing amount of
RBP added to the reaction did not have an effect on the shift of the short-labeled RNA
probe. There is no shift observed in the reaction containing lysozyme and short RNA probe.

Figure 24: EMSA dose dependent reaction with increasing concentration of RBP
protein incubated with “short” RNA probe. No shift in short probe. Lysozyme was
used as negative control.
4.3.

Protein-RNA Pulldown

4.3.1

RBP Purification
The next aim was to isolate the protein-RNA complexes and sequence the P.

gingivalis W83 RNAs bound to candidate RNA-binding proteins. This was accomplished
using protein-RNA pulldowns to isolate RNA by its interaction with protein. In order to
ensure the candidate protein would bind properly to P. gingivalis RNA, the protein needed
to be quite pure and expressed well. The RBP his-tag purification method using Ni-resin
(Fig. 25) showed high expression, but also shows high amounts of RBP in flow-through,
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yielded elution with high amounts of unwanted proteins, and low concentrations of
recombinant protein in elutions. An alternate method of purification needed to be used in
order to obtain more pure samples of RBP.

Figure 25: SDS-PAGE analysis of his-tag purification of RBP under denaturing
conditions. RBP is approximately 16kD. 12% Bis-Tris gel was used for the analysis.
Lane 1: Ladder, Lane 2: Flow-through, Lane 3: RBP purification elution, Lane 4: RBP
purification elution
In order to purify RBP adequately, a size exclusion column was used. This method
provided very pure samples of RBP with higher concentrations than the Ni-resin method
(Fig. 26). RBP purified without background noise. RBP is approximately 15kD. The RBP
samples from the size exclusion were then dialyzed in RNase free binding buffer in
preparation for the protein-RNA Pulldown using Dynabeads (Novex by Life
Technologies).
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Figure 26: SDS-PAGE analysis of RBP purification using size exclusion. 12% Bis-Tris
gel was used for the analysis. Two elutions of RBP isolated using size exclusion shown
with ladder.
4.3.2. RNA Isolation from P. gingivalis W83
In order to investigate candidate proteins’ ability to bind RNA in P. gingivalis,
RNA was isolated from P. gingivalis W83 using the Qiagen RNA isolation kit. The
isolated RNA was run on RNase free agarose gel to determine the quality of the RNA. Gel
electrophoresis of RNA showing two bands representing the non-degraded, intact
ribosomal RNA (Fig. 27). The RNA was treated with DNase and incubated with candidate
proteins to allow for protein-RNA complexes to form.
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Figure 27: Gel Electrophoresis of isolated P. gingivalis W83 RNA. Lane 1: RNA
isolation prep 1, Lane 2: RNA isolation prep 2.
4.3.3. Dynabead Pulldown
To allow for protein-RNA complexes to form, the size exclusion purified RBP,
and Ni-resin purified HUβ and HUα were thoroughly dialyzed in RNase free binding
buffer. The proteins were then incubated with isolated P. gingivalis W83 RNA to allow
for interaction. The pulldown was performed as described in “Materials and Methods” to
isolate P. gingivalis RNA based on its interaction with the candidate proteins. Samples
from each pulldown were run on denaturing SDS-PAGE to confirm protein was present in
elution (Fig. 28). Based on the SDS-PAGE shown in Figure 28, RBP purified using size
exclusion failed to bind to Dynabeads. The HUβ and HUα bound to Dynabeads and could
be recovered in elution. I could proceed with the pulldown of HUβ and HUα, but an
alternative isolation technique for RBP needed to be used.
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Figure 28: SDS-PAGE analysis of aliquots from Protein-RNA Pulldown. 12% BisTris gel was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot from RBP(size
exclusion purified) + RNA Pulldown, Lane 3: Aliquot from HUβ + RNA Pulldown, Lane
4: Aliquot from HUα + RNA Pulldown
4.4.

Generation of genetic construct coding for RBP with C-terminal His-tag
In attempt to improve RBP his-tag binding to Ni resin and cobalt Dynabead, we

generated new recombinant DNA with the his-tag on the C-terminus. Using the primer
listed in “Materials and Methods”, PCR was performed to amplify gene PG0565. We used
gel electrophoresis to confirm the fragment size to be about 300bp (Fig. 29). We could
then move on to clone the gene insert into vector pCR2.1.
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Figure 29: Gel Electrophoresis of the PCR product for cloning PG0565 for Cterminal His-tag. Lane 1: Ladder, Lane 2: PCR product
In order to clone the PCR product, pCR2.1 vector was used and transformed into
OneShot Top10 competent E. coli (Invitrogen). The transformation was plated using IPTG
and X-gal to screen for plasmid with insertion of the genes. White colonies were cultured
overnight and plasmids were purified using Q1prep Sin Miniprep Kit (Qiagen). Plasmids
were digested with EcoRI in order to confirm the insertion of desired gene (Fig. 30). As
expected, PG0565 is approximately 300bp and pCR2.1 is approximately 3.9kb. The insert
could then be digested out to insert into pET-30a.
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Figure 30: Gel Electrophoresis to screen colonies for insertion of PG0565 using
restriction enzyme EcoRI. Lane 1: Ladder, Lane 2: Recombinant plasmid pCR2.1-RBP
digested with EcoRI.
To produce the C-terminal his-tagged recombinant protein RBP, the gene PG0565
needed to be cloned into vector pET-30a. The gene was digested out of pCR2.1 using
XhoI and NdeI. As expected, PG0565 is approximately 300bp and pCR2.1 is
approximately 3.9kb. The plasmid pET-30a (approximately 5.4kb) was also digested with
the same restriction enzymes and sticky end ligation could be performed (Fig. 31).
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Figure 31: Gel Electrophoresis of pCR2.1-PG0565 and pET-30a digested with XhoI
and NdeI. Lane 1: Ladder, Lane 2: pCR2.1-PG0565 digested with XhoI and NdeI, Lane 3:
pET-30a digested with XhoI and NdeI.
PG0565 gene and vector pET-30a were ligated using T4 DNA Ligase and
transformed into e α-Select Silver E. coli (Bioline). To insure insertion of PG0565 in pET30a, the transformations were screened on kanamycin LB plates and colonies were
cultured overnight in 20mL of LB media. The pET-30a plasmids with insertion were
purified using the Q1prep Spin Miniprep Kit. In order to verify insertion of appropriate
gene, we digested the plasmid with restriction enzymes NcoI and NdeI and ran the
digestion on agarose gel (Fig. 32). As expected, vector pET-30a is approximately 5.4kb
and PG0565 is approximately 300bp. The plasmid appeared to be pure and we could move
on to expression of the recombinant RBP.
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Figure 32: Gel Electrophoresis of pET-30a-PG0565 digested with XhoI and NdeI to
confirm content of the plasmid. Lane 1: Ladder, Lane 2: Recombinant plasmid pET-30aPG0565 digested with XhoI and NdeI.
After validating gene insertion into pET-30a, the plasmid was then transformed
into BL21 E. coli. We used BL21 chemically competent E. coli cells because they are
suitable for transformation and protein expression. The BL21 strain was used to express
and purify recombinant proteins as described in “Materials and Methods”. The elutions
from the his-tag purification on Ni-resin were run on denaturing protein gels to show
protein expression and purity (Fig. 33). Flow-through shows a large amount of RBP
coming out in solution. His-tag RBP elution 1 shows two bands of RBP. The elution 2
shows a pure band of RBP that we used to continue to the pulldown.

57

Figure 33: SDS-PAGE analysis of RBP purified with C-terminal his-tag
chromatography. 12% Bis-Tris gel was used for the analysis. Lane 1: Flow-through,
Lane 2: His-tag RBP elution 1, Lane 3: His-tag RBP elution 2.
4.5.

Repurification and concentration of RBP, HUβ and HUα
In order to concentrate the his-tag proteins that could bind efficiently to Dynabeads

during pulldown, the proteins were repurified on the Dynabeads according to protocol.
Samples form the protein elutions were run on SDS-PAGE to confirm purity and
concentration (Fig. 34). The results showed pure bands of adequate concentration to
continue to the protein-RNA pulldown on dynabeads. The elutions from the repurification
showed one band representing the pure recombinant proteins. RBP with His-tag on the Cterminus is 12kDa due to a shorter linker sequence than the C-terminal His-tag. HUβ and
HUα are both about 16kDa. The candidate proteins were of good purity and could then be
used to perform His-tag protein-RNA pulldown on Dynabeads (Novex by Life
Technologies).
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Figure 34: SDS-PAGE analysis of re-purification using Dynabeads. 12% Bis-Tris gel
was used for the analysis. Lane 1: Re-purified RBP, Lane 2: Re-purified HUβ, Lane 3: Repurified HUα
4.6.

His-Tag RNA-Protein Pulldown
In order to isolate P. gingivalis RNA based on protein binding, the candidate

RNA-binding proteins were thoroughly dialyzed in RNase free binding buffer. P.
gingivalis RNA that was isolated and treated with DNase was then added to the re-purified
RBP, HUβ and HUα. The RNA-protein mixture was incubated on a rotator to allow
binding. The mixture was then applied to Dynabeads. The pulldown was performed
according to Dynabead protocol (Invitrogen) using nuclease free buffers as listed in
“Materials and Methods”. Samples from the pulldown were run on SDS-PAGE denaturing
gel to confirm presence of protein in elution (Fig. 35). As seen in the SDS-PAGE
analysis, each protein was recovered from the protein-RNA pulldown. From here we
could move on to treating the complexes with protease to release the RNA from the
protein-RNA complex for RNA-seq.
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Figure 35: SDS-PAGE analysis of protein-RNA pulldown using his-tag on
dynabeads. 12% Bis-Tris gel was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot
from Pulldown of re-purified RBP + P. gingivalis W83 RNA, Lane 3: Aliquot from
Pulldown of re-purified HUβ + P. gingivalis W83 RNA, Lane 4: Aliquot from Pulldown
of re-purified HUα + P. gingivalis W83 RNA
4.6.1. Protein-RNA pulldown using Halo-Tag
In order to perform another pulldown assay with the candidate proteins, the genes
were inserted into pCF20K HaloTag vector. HaloTag purification was used to isolated P.
gingivalis RNA based on it’s binding to the candidate protein. The pFC20K HaloTag
plasmids with PG0565, PG0121, and PG1258 gene inserts were transformed into BL21
and expressed using IPTG. The induced cell cultures were lysed, and the lysate was then
applied to the resin and incubated to allow for the HaloTag to bind covalently to the resin.
P. gingivalis RNA was added to each of the resin-bound proteins and incubated to allow
protein and RNA to interact. The resin-bound proteins were washed thoroughly with
RNase free pulldown buffer. TEV mix was added to each sample to cleave the protein
from the resin in order to elute the protein. Samples from the pulldown were run on SDSPAGE denaturing gel to confirm presence of protein in elution (Fig. 36). As seen in the
SDS-PAGE analysis, each protein was recovered from the protein-RNA pulldown. From
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here we could move on to treating the complexes with protease to release the RNA from
the protein-RNA complex for RNA-seq.

Figure 36: SDS-PAGE analysis of HaloTag proteins from pulldown. 12% Bis-Tris gel
was used for the analysis. Lane 1: Ladder, Lane 2: Aliquot from halo-tag Pulldown of
RBP + P. gingivalis W83 RNA, Lane 3: Aliquot from halo-tag Pulldown of HUβ + P.
gingivalis W83 RNA, Lane 4: Aliquot from halo-tag Pulldown of HUα + P. gingivalis
W83 RNA
4.7.

RNA Library Generation
P. gingivalis RNA was released from bound protein by treatment with protease

from Streptomyces griseus (Sigma, P8811). The RNA was isolated as described in the
“Materials and Methods” and used to generate an RNA library. Using reverse
transcription, cDNA was generated and PCR was used to amplified the cDNA strands.
The library generated was then sent to the sequencing center (VCU Sanger Hall) to be
validated and sequenced.
4.7.1. Validation of RNA-Seq Library using the BioAnalyzer
Before continuing to high throughput sequencing, the quality of the RNA was
analyzed using the bioanalyzer. The peaks represent the cDNA fragment lengths (bp).
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A distinct peak spanning 150-1,000 bp, peaked at about 300 bp for the RNA sample yields
product greater than 7.5 nM RNA-seq Library. The accuracy of the sequencing is optimal
for strands under 1,000bp. The results for the samples (Fig. 37-42) showed that the cDNA
was suitable for further processing.

Figure 37: Electropherogram results from bioanalyzer of P. gingivalis RNA from
RBP-RNA His-Tag pulldown

Figure 38: Electropherogram results from bioanalyzer of P. gingivalis RNA from
HUβ-RNA His-Tag pulldown
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Figure 39: Electropherogram results from bioanalyzer of P. gingivalis RNA from
HUα-RNA His-Tag pulldown

Figure 40: Electropherogram results from bioanalyzer of P. gingivalis RNA from
RBP-RNA HaloTag pulldown

Figure 41: Electropherogram results from bioanalyzer of P. gingivalis RNA from
HUβ-RNA HaloTag pulldown
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Figure 42: Electropherogram results from bioanalyzer of P. gingivalis RNA from
HUα-RNA HaloTag pulldown
4.7.2. High throughput sequencing of RNA libraries
The samples were then sequenced using Rapid flow cell (VCU Sanger Hall). From
the high throughput sequencing results, we were able to align the DNA fragments along
the P. gingivalis genome (Fig. 43). Across the whole P. gingivalis genome showed areas
of high copy numbers. There was not much variation between RBP and HU proteins. Also
the areas of highest copy numbers were genes encoding for ribosomal RNA. Statistical
analysis was then used to further examine the difference in genome locus binding sites
between RBP, HUβ and HUα.
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Figure 43: High throughput sequencing reads aligned with P. gingivalis genome
4.7.3. Statistical Analysis of RNA-sequencing results
Statistical analysis allowed us to compare the reads per kilo base per million
mapped reads (RPKM) from His-tagged RBP and His-tagged HUβ (Table 8), as well as
Halotag RBP and His-tag HUβ (Table 9). The fold change gives us a ratio that allows us
to see an increase in binding of RBP compared to the HU protein. From results not shown,
the area of highest copy numbers among RBP, HUβ and HUα are16S and 23S ribosomal
RNA. This non-specific binding was disregarded and we examined other gene loci to
investigate possible significant protein binding sites along the P. gingivalis genome.
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Table 8: P. gingivalis genes most significantly bound to His-tagged RBP compared to
His-tagged HUβ determined using RNA-seq analysis. A. Locus ID based on Los
Alamos, B. Definition based on BROP genome viewer, C. Reads per kilo base per million
mapped reads (RPKM)-His-tag RBP, D. Reads per kilo base per million mapped reads
(RPKM)-His-tag HUβ, E. Ratio of the number of reads that align at each position from
RBP to the reads from HUβ.

Locus
ID
A
PG1828
PG1085
PG1421
PG0607
PG2213
rpsO
PG0555
PG0195
PG1196

Definition
B
Cation efflux system protein
probable peptidyl-prolyl cis-trans
isomerase
hypothetical protein
indolepyruvate ferredoxin
oxidoreductase alpha subunit
oxidoreductase, short chain
dehydrogenase-reductase family
short-chain dehydrogenase
hypothetical protein
ABC transporter protein, ATPbinding protein
prolyl tripeptidyl peptidase (Ptp-A)
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RPKM
RBP
His
C
71.29

RPKM
HUβ
His
D
5.18

ExperimentFold Change
RBP His/HUB
His
E
13.77

104.19
51.80

15.94
9.03

6.54
5.74

43.57

9.72

4.48

34.57
65.62
38.20

8.44
18.78
11.05

4.10
3.49
3.46

269.56
4.14

91.41
0

2.95
0

Table 9: P. gingivalis genes most significantly bound to Halotag RBP compared to
His-tagged HUβ determined using RNA-seq analysis. A. Locus ID based on Los
Alamos, B. Definition based on BROP genome viewer, C. Reads per kilo base per million
mapped reads (RPKM)-Halotag RBP, D. Reads per kilo base per million mapped reads
(RPKM)-His-tag HUβ, E. Ratio of the number of reads that align at each position from
RBP to the reads from HUβ.

Locus
ID
A
PG1828
PG1196
PG1574
PG1206
PG1655
PG0822
PG1445
PG1223
PG1722
PG1373
PG1866
greA
coaD
PG1451
PG0507
PG0408
PG1980
PG0007
PG0161
PG1978
PG1449
PG1203
menA

Definition
B
Cation efflux system protein
prolyl tripeptidyl peptidase (Ptp-A)
hypothetical protein
uridine phosphorylase
probable tonB-linked outer
membrane receptor
Hypothetical protein
methylmalonyl-CoA mutase alpha
subunit
rod shape-determining protein
hemagglutinin hagB
conserved hypothetical protein
hypothetical protein
transcription elongation factor
(GreA) (trancript cleavage factor)
phosphopantetheine
adenylyltransferase
ABC transporter protein, ATPbinding protein
conserved hypothetical protein
molybdopterin synthase
sulphurylase
hypothetical protein
ISPg5 transposase
cell surface protein fragment
(fimbrillin-related)
hypothetical protein
RNA polymerase sigma factor,
ECF subfamily (sigma-70)
glucose-6-phosphate isomerase
1,4-dihydroxy-2-naphthoate
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RPKM
RBP
Halo
C
638.87
4.02
4.02
4.15

RPKM
HUβ
His
D
5.18
0
0
0

Experiment Fold Change
RBP Halo/HUB
His
E
123.42
0
0
0

4.39
4.52

0
0

0
0

4.70
6.02
6.02
8.90
14.63

0
0
0
0
0

0
0
0
0
0

9.78

0.94

10.45

9.31

0.95

9.75

10.54
11.03

1.08
1.13

9.75
9.75

9.20
16.17
17.39

1.24
1.29
1.39

7.43
12.54
12.54

14.33
22.48

1.47
2.51

9.75
8.95

16.24
40.96
32.52

2.59
3.15
4.47

6.27
13.00
7.27

PG1358
PG0423
PG1186
PG0650
PG0115
PG0119
PG1276
PG0173

octaprenyltransferase (DHNAoctaprenyltransferase)
tonB-dependent receptor HmuR (or
HemR)
folylpolyglutamate synthase
hypothetical protein
response regulator
phosphoglycerate mutase
Mg2+ transport protein MgtE (CBS
domain)
hypothetical protein
hypothetical protein
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25.71
56.88
30.10
29.60
39.27

4.53
4.54
4.57
4.59
5.03

5.67
12.54
6.59
6.44
7.80

30.32
47.86
122.35

5.05
6.09
6.23

6.01
7.86
19.64

CHAPTER 5: DISCUSSION

Gene regulation is vital for bacterial adaptation to dynamic environments.
Riboregulation is becoming more widely accepted as a prominent form of gene regulation
in bacterial organisms. The ability of P. gingivalis to survive in the challenging
environment of the oral cavity leads us to believe that it also uses riboregulation,
specifically RNA-binding proteins, to rapidly adapt and regulate its gene expression in
response to stress. However as of yet, no RNA-binding protein has been reported to be
present in P. gingivalis.
Using bioinformatics, my lab has identified three proteins of interest: RBP
(PG0565, PG0627), HUβ (PG0121) and HUα (PG1258) in P. gingivalis that were further
investigated as putative RNA-binding proteins. BROP shows that RBP shares sequence
homology with putative RNA-binding proteins of other pathogens. RBP is a strong RNAbinding protein candidate to investigate because unpublished data in the Lewis lab shows
that the knock out PG0565 mutant cannot survive with eukaryotic cells. If RBP’s target
RNA can be identified, it may aid in the development of alternate treatment for chronic
periodontitis.
HUβ and HUα were previously selected as controls due to the likelihood that these
proteins also bind RNA in P. gingivalis. HUβ and HUα are among the P. gingivalis
proteins annotated by BROP as histone-like DNA-binding proteins that are related to HU.
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The gene PG0121 encodes a functional homologue for E. coli HU and shares a 76.7%
sequence similarity to the E. coli HUβ (Pearson & Lipman, 1988; Priyadarshini et al.,
2013). In E. coli, HU binds to single stranded DNA, and also has been shown to bind
mRNA (Balandina et al., 2001). The ability of P. gingivalis HUβ to bind to RNA has not
been tested (Tjokro et al., 2014), but it is hypothesized that HUβ binds mRNA to increase
expression of the K-antigen capsule.
I hypothesized that RBP, HUβ and HUα bind RNA in P. gingivalis. The first aim
was to show that RBP, HUβ, and HUα bind to RNA. EMSA was used to show interactions
between RNA and protein, visible by a shift in the labeled RNA. The second aim was to
isolate P. gingivalis RNA-protein complexes and sequence the P. gingivalis RNA. Histag and halotag pulldowns were used to isolate the complexes and sequence the RNA.
In order to test the binding of RBP, HUβ, and HUα with RNA, it was important to
obtain pure samples of RBP, HUβ and HUα with low background of other proteins. The
purification of RBP using the His-tag on the C-terminus was not effective. RBP was well
expressed but was coming out in the flow through (Fig. 25). This could be due to the
secondary structure of the protein hiding the His-tag making it inaccessible to the Ni-resin.
Also, the elutions contained background of other proteins because we could not wash as
stringently with IMD. We attempted to optimize the wash buffer IMD concentration and
volume, but RBP came out in wash and still lacked purity.
Size exclusion method was then used in attempt to further purify RBP. This
method provided pure samples with no background and yielded adequate amounts of RBP
needed for EMSA and the pulldowns (Fig. 26). The HUβ and HUα his-tag proteins
purified from the Ni-resin without issues and allowed us to move on to EMSA and the his-
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tag pulldown on the dynabeads. As will be discussed later in further detail, RBP from the
size exclusion purification was unable to be recovered from his-tag pulldowns (Fig. 28).
RBP isolated from the size exclusion did not isolate the protein based on its ability to bind
to Ni-resin. Therefore, when the RBP was applied to the Dynabead, the His-tag of the
protein was not adequately exposed and was unable to bind to the cobalt Dynabead. This
was an issue because normally cobalt binds His-tag more efficiently than Ni-resin, but we
still could not recover the RBP from the Dynabead. This led us to the generation of a
genetic construct coding for RBP with an C-terminal his-tag. RBP with a C-terminal histag purified more efficiently than the RBP with C-terminal his-tag (Fig. 33) and we were
able to use pure RBP samples for both EMSA and his-tag pulldowns. The more successful
purification of the construct with the His-tag on the C-terminal could be due to the protein
secondary structure folding with C-terminus on the interior and the C-terminus on the
exterior surface.
EMSA was used to characterize the interaction of RBP, HUβ and HUα with IRE
RNA and the interaction of RBP with synthesized RNA motifs. In binding reaction I
(Table 5), the probe used was biotinylated IRE RNA. IRE RNA was incubated with RBP
as the experimental protein, HUβ and HUα as controls, and lysozyme as the negative
control. An unlabeled IRE RNA was used as a competitor RNA. The results (Fig. 21)
showed that the RBP did not cause the IRE RNA to shift. HUβ and HUα bind IRE RNA,
as well as the negative control, Lysozyme, indicating an interaction with the IRE RNA.
The reactions containing unlabeled IRE RNA for HUβ and HUα showed a decrease in
shifted probe with the addition of competitor RNA. This indicates that the binding of IRE
RNA with HUβ and HUα is specific. Lysozyme shifts IRE RNA without much variability
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in the presence of competitor RNA. This indicates that the binding is non-specific and the
conditions were optimal for the binding of IRE RNA with Lysozyme.
In order to further investigate the RBP interaction with IRE RNA, we gradually
increased the amounts of RBP in binding reaction II (Table 6). The dose dependent
reaction showed an increase in what seemed to be a shift, and a decrease in overall shift
with the addition of the competitor RNA (Fig. 22). Upon a second look, the “shift”
appeared to be similar to the control lane containing no protein (Fig. 22, Lane 1). The IRE
RNA in lane 1 may be forming bulky motifs causing a shift without the addition of
protein. Control lanes 2 and 3 show a shift leaving behind residual unbound RNA. This
serves as a good mark for the baseline. The reactions containing RBP do shift the RNA
from this baseline.
The interaction of RBP with RNA needed to be further tested; so specific
biotinylated RNA motifs were generated based on motifs commonly associated with
protein-RNA binding (Chen & Varani, 2013; Kang et al., 2006; Blakeley et al., 2013;
Keiler, 2012). The probes were named “long” and “short” based on their size. The long
RNA probe contained more motifs, while the short RNA probe contained some of the
same motifs.
Binding reaction III (Table 7) used the long probe incubated with RBP in
increasing amounts starting with no protein. Lysozyme was used as the negative control.
The results (Fig. 23) showed a shift in the probe by RBP indicating RBP binds RNA.
Also, it should be noted that the baseline representing residual unbound RNA decreases as
more RBP is added. In lane 1 of figure 23, there is a shift seen without RBP added. The
shift above the black box is present in each lane of the reaction. This may be due to the
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RNA forming secondary structures. In the attempt to alleviate this problem, the RNA was
boiled to denature the RNA and then kept on ice through the duration of the experiment.
Due to the nature of the experiment there was time spent with the RNA at room
temperature, which may have allowed the RNA to reform its secondary structures.
The next reaction, binding reaction IV (Table 7), used the short RNA probe with
increasing amounts of RBP and lysozyme as the negative control. The results (Fig. 24)
show no shift in the short probe as RBP increases. This information is helpful to us
because it narrows down the possible motifs the protein binds. The results from both the
long probe and short probe dose dependent reactions show that RBP binds to specific
motifs or sequences of RNA.
The second aim was to isolate P. gingivalis RNA-protein complexes and sequence
the P. gingivalis RNA. In order to isolate RNA from the protein-RNA complex, it was
important to obtain pure samples of RBP, HUβ and HUα with low background of other
proteins. The purification of RBP using the His-tag on the C-terminus was not effective.
Even though RBP was well expressed, a lot of the protein was coming out in the
flowthrough. In addition, it was difficult to obtain pure elutions without heavy background
of other proteins. After attempting to optimize the wash buffer IMD concentration and
volume, RBP elutions were still not pure and RBP was coming out in wash and visible on
SDS-PAGE analysis.
The next attempt to obtain pure samples of RBP was the use of size exclusion
purification. This method provided pure samples of RBP with no background and high
concentrations (Fig. 26). The HUβ and HUα his-tag proteins purified from the Ni-resin
without issues and provided pure samples for the his-tag pulldown on the dynabeads.
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The results from the pulldown using size exclusion purified RBP (Fig. 28) show no
RBP isolated. HUβ and HUα were able to be isolated from the dynabeads. There is some
degradation of HUβ and HUα visible by SDS-PAGE analysis. The his-tag of RBP was not
binding to the Ni-resin or the dynabeads as efficiently as HUβ and HUα. The
conformation of RBP may fold in a way that makes the his-tag on the C-terminus
inaccessible. In order to resolve this problem, we generated a genetic construct coding for
RBP with a C-terminal His-tag.
RBP with the C-terminal His-tag was more efficiently purified on Ni-resin (Fig.
33). After purifying RBP, HUβ and HUα on the Ni-resin, the protein samples were then
repurified on dynabeads to concentrate and optimize the pulldown (Fig. 34). Also, the
purification on dynabeads provided a means to concentrate the samples since 700 µL were
applied to the beads, and 50 µL were eluted. The samples from the repurification were
then incubated with P. gingivalis RNA pretreated with DNase, and Dynabeads were used
to isolate the protein-RNA complex. Aliquots from the pulldowns were run on SDSPAGE to allow us to analyze the isolation of at least the protein of the protein-RNA
complex (Fig. 35).
The use of the Halotag was initiated due to the difficulties purifying RBP with the
C-terminal his-tag. RBP, HUβ and HUα were cloned into a Halotag vector for Halotag
pulldowns. The Halotag isolation yielded more pure samples of RBP, HUβ and HUα. The
nature of the Halotag allows stringent washes because it forms a covalent bond with the
resin. After the successful purification of RBP with the C-terminal his-tag, we still
continued with the Halotag pulldown (Fig. 36) because it would serve as a biological
replicate. The Halotag pulldowns were analyzed on SDS-PAGE and showed we were
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able to isolate RBP, HUβ and HUα. The elutions from both the his-tag and Halotag
pulldowns were then used to generate RNA libraries.
Treating the samples with protease degraded the protein to release the RNA from
the complex. RNA cleanup was then used to obtain pure RNA samples to use for
sequencing. The RNA sequencing kit (Clontech) uses less than nanogram amounts of
RNA to generate cDNA and amplify cDNA by PCR. Before investing in sequencing, the
samples were tested for quality using a bioanalyzer (Figures 37, 38, 39, 40, 41, & 42).
This measured the base pairs of the cDNA fragments. Fragments under 1,000 bp were
ideal to provide sequence information. Fragments from the HUβ Halotag pulldown were
longer than 1,000 bp and did not provide useful data.
The sequencing results allowed us to align the reads of the cDNA fragments with
the P. gingivalis genome and to compare reads from RBP to HUβ and HU control
pulldowns. The sequencing results showed high copy numbers of reads across the P.
gingivalis genome for both the experimental protein and controls (Fig. 43). One possible
explanation for this could be that the RNA in the protein-RNA complex is a long strand
containing many genes. If the RNA was fractionated, this could resolve this issue of high
amounts of reads across the whole genome. Another issue was the high amounts of 16S
and 23S rRNA sequenced from the pulldowns. The use of whole cell RNA for the
pulldowns allowed rRNA to bind to RBP, HUβ and HUα. rRNA depletion should be
done to alleviate the problem of the rRNA binding non-specifically to the proteins in vitro.
Also we have moved on to in vivo studies to obtain more biologically relevant data and to
decrease the binding of 16S and 23S rRNA.
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The in vivo study will use immunoprecipitation of RBP-RNA complex from P.
gingivalis. P. gingivalis W83 and mutant protein-RNA complexes will be cross-linked,
lysed and sonicated to fractionate the RNA. The RBP-RNA complex will be isolated
using RBP specific antibody. Western blot will be used to detect the presence of RBP. The
samples will then be treated with protease and used for RNA sequencing. We can then use
these sequencing results to help us analyze the reads along the P. gingivalis genome where
RBP binds.
We have tested the binding of RBP with RNA from P. gingivalis and shown that
there is an interaction between the two. From the EMSA reactions using IRE RNA, we see
that RBP binds to RNA differently than HUβ and HUα. Also, the EMSA reactions using
the long probe and short probe show that RBP binds specifically to RNA motifs. The in
vitro studies also indicate that RBP binds with RNA from P. gingivalis, but further studies
should be done to identify the specific binding sites and the molecular mechanism
governing the RBP-mediated regulation.
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